Drugs / Dihydroartemisinin/piperaquine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02992119 | Jun 2017 → Feb 2018 | malaria | University of Oxford | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dihydroartemisinin/piperaquine | “DHA-PIP = Dihydroartemisinin/piperaquine PQ = Primaquine” NCT02992119 ↗ |
| Known as | DHA-PIP | “DHA-PIP = Dihydroartemisinin/piperaquine PQ = Primaquine” NCT02992119 ↗ |